Twist Bioscience Corporation (TWST)

Name: Twist Bioscience Corporation Financial Statements
Creator: Quarter Results

Healthcare | Medical Diagnostics Research

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$104M

Net Income

-$30.5M

Operating Margin

-31.7%

Free Cash Flow

-$75.6M

Debt / Assets

26.3%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Twist Bioscience Corporation (TWST).
Income Statement (Quarterly)	2025-12-31	2025-03-31	2024-12-31	2024-09-30
Revenue	103,698,000	92,793,000	88,713,000	84,710,000
Cost of Revenue	49,726,000	46,765,000	45,873,000	46,477,000
Gross Profit	53,972,000	46,028,000	42,840,000	38,233,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	69,742,000	63,672,000	56,177,000	53,143,000
Operating Expenses	86,872,000	87,589,000	77,484,000	74,277,000
Operating Income	-32,900,000	-41,561,000	-34,644,000	-36,043,000
Interest Expense	0	-190,000	24,000	29,000
Income Before Tax	-30,254,000	-39,696,000	-31,497,000	-34,751,000
Income Tax Expense	253,000	-368,000	97,000	-96,000
Net Income	-30,507,000	-39,328,000	-31,594,000	-34,655,000
Per Share
EPS	-0.50	-0.66	-0.53	-0.60
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Twist Bioscience Corporation (TWST).
Income Statement (Annual)	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Revenue	376,572,000	312,974,000	245,109,000	203,565,000	132,333,000
Cost of Revenue	185,570,000	179,625,000	155,380,000	119,330,000	80,620,000
Gross Profit	191,002,000	133,349,000	89,729,000	84,235,000	51,713,000
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	246,976,000	218,398,000	189,738,000	212,949,000	135,901,000
Operating Expenses	327,261,000	354,180,000	306,888,000	333,256,000	204,973,000
Operating Income	-136,259,000	-220,831,000	-217,159,000	-249,021,000	-152,726,000
Interest Expense	0	29,000	5,000	80,000	367,000
Income Before Tax	-76,951,000	-208,166,000	-203,466,000	-228,274,000	-154,028,000
Income Tax Expense	719,000	560,000	1,152,000	-10,411,000	-1,930,000
Net Income	-77,670,000	-208,726,000	-204,618,000	-217,863,000	-152,098,000
Per Share
EPS	-1.30	-3.60	-3.60	-4.04	-3.15
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Twist Bioscience Corporation (TWST).
Balance Sheet (Quarterly)	2025-09-30	2024-09-30	2023-09-30	2022-09-30
Assets
Cash and Cash Equivalents	183,049,000	226,316,000	286,470,000	378,687,000
Short Term Investments	49,385,000	50,083,000	49,943,000	126,281,000
Net Receivables	57,019,000	34,903,000	44,064,000	40,294,000
Inventory	28,309,000	24,078,000	32,063,000	39,307,000
Total Current Assets	332,966,000	346,776,000	424,256,000	596,483,000
Property Plant Equipment	151,660,000	161,349,000	203,361,000	214,389,000
Goodwill and Intangibles	95,620,000	100,289,000	140,294,000	145,549,000
Total Assets	641,861,000	614,323,000	776,403,000	961,378,000
Liabilities
Account Payables	11,094,000	1,630,000	14,052,000	20,092,000
Short Term Debt	27,644,000	14,805,000	14,896,000	13,642,000
Total Current Liabilities	91,406,000	71,006,000	73,323,000	90,663,000
Long Term Debt	61,750,000	70,221,000	79,173,000	81,270,000
Total Liabilities	168,903,000	141,634,000	152,971,000	171,993,000
Shareholders Equity
Retained Earnings	-1,319,578,000	-1,241,908,000	-1,033,034,000	-828,416,000
Total Shareholders Equity	472,958,000	472,689,000	623,432,000	789,385,000

Balance sheet annual history for Twist Bioscience Corporation (TWST).
Balance Sheet (Annual)	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Assets
Cash and Cash Equivalents	183,049,000	226,316,000	286,470,000	378,687,000	465,829,000
Short Term Investments	49,385,000	50,083,000	49,943,000	126,281,000	12,034,000
Net Receivables	57,019,000	34,903,000	44,064,000	40,294,000	28,549,000
Inventory	28,309,000	24,078,000	32,063,000	39,307,000	31,800,000
Total Current Assets	332,966,000	346,776,000	424,256,000	596,483,000	546,495,000
Property Plant Equipment	151,660,000	161,349,000	203,361,000	214,389,000	105,702,000
Goodwill and Intangibles	95,620,000	100,289,000	140,294,000	145,549,000	40,696,000
Total Assets	641,861,000	614,323,000	776,403,000	961,378,000	702,097,000
Liabilities
Account Payables	11,094,000	1,630,000	14,052,000	20,092,000	14,900,000
Short Term Debt	27,644,000	14,805,000	14,896,000	13,642,000	9,765,000
Total Current Liabilities	91,406,000	71,006,000	73,323,000	90,663,000	63,052,000
Long Term Debt	61,750,000	70,221,000	79,173,000	81,270,000	53,156,000
Total Liabilities	168,903,000	141,634,000	152,971,000	171,993,000	121,276,000
Shareholders Equity
Retained Earnings	-1,319,578,000	-1,241,908,000	-1,033,034,000	-828,416,000	-610,553,000
Total Shareholders Equity	472,958,000	472,689,000	623,432,000	789,385,000	580,821,000

Cash flow quarterly history for Twist Bioscience Corporation (TWST).
Cash Flow Statement (Quarterly)	2025-09-30	2024-09-30	2023-09-30	2022-09-30
Operating Activities
Net Income	-77,670,000	-208,726,000	-204,618,000	-217,863,000
Depreciation & Amortization	24,853,000	31,432,000	29,310,000	16,514,000
Stock Based Compensation	64,459,000	50,925,000	30,278,000	79,664,000
Change in Working Capital	-12,606,000	15,411,000	-1,009,000	-5,356,000
Operating Cash Flow	-47,628,000	-64,094,000	-142,474,000	-124,385,000
Investing Activities
Capital Expenditure	-28,004,000	-5,076,000	-27,779,000	-101,857,000
Investments	-28,004,000	-5,076,000	-27,779,000	-101,857,000
Investing Cash Flow	-24,762,000	-3,071,000	50,612,000	-232,930,000
Financing Activities
Debt Repayment	0	0	0	-1,558,000
Common Stock Issued/Repurchased	13,540,000	-3,975,000	911,000	262,068,000
Dividends Paid	0	0	0	0
Financing Cash Flow	28,540,000	6,890,000	911,000	270,534,000
Summary
Free Cash Flow	-75,632,000	-69,170,000	-170,253,000	-226,242,000
Net Change in Cash	-43,267,000	-60,149,000	-90,978,000	-87,100,000

Cash flow annual history for Twist Bioscience Corporation (TWST).
Cash Flow Statement (Annual)	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Operating Activities
Net Income	-77,670,000	-208,726,000	-204,618,000	-217,863,000	-152,098,000
Depreciation & Amortization	24,853,000	31,432,000	29,310,000	16,514,000	9,750,000
Stock Based Compensation	64,459,000	50,925,000	30,278,000	79,664,000	36,998,000
Change in Working Capital	-12,606,000	15,411,000	-1,009,000	-5,356,000	-9,381,000
Operating Cash Flow	-47,628,000	-64,094,000	-142,474,000	-124,385,000	-112,244,000
Investing Activities
Capital Expenditure	-28,004,000	-5,076,000	-27,779,000	-101,857,000	-27,061,000
Investments	-28,004,000	-5,076,000	-27,779,000	-101,857,000	-27,061,000
Investing Cash Flow	-24,762,000	-3,071,000	50,612,000	-232,930,000	156,155,000
Financing Activities
Debt Repayment	0	0	0	-1,558,000	-3,333,000
Common Stock Issued/Repurchased	13,540,000	-3,975,000	911,000	262,068,000	313,012,000
Dividends Paid	0	0	0	0	0
Financing Cash Flow	28,540,000	6,890,000	911,000	270,534,000	329,182,000
Summary
Free Cash Flow	-75,632,000	-69,170,000	-170,253,000	-226,242,000	-139,305,000
Net Change in Cash	-43,267,000	-60,149,000	-90,978,000	-87,100,000	373,113,000